| Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
|---|
| 07/14/1999 | EP0928336A1 Chaperone fragments |
| 07/14/1999 | EP0928291A1 3-mercaptoacetylamino-1,5-substituted-2-oxo-azepan derivatives useful as inhibitors of matrix metalloproteinase |
| 07/14/1999 | EP0804179B1 Use of n-acyl derivatives of aminoalcohols in the manufacture of a medicament for practising neuroprotective action in neuropathological states connected with excitotoxicity |
| 07/14/1999 | EP0777649B1 N- 2-(pyrrolidinyl-1)-1-phenylethyl]acetamides as kappa receptor agonists |
| 07/14/1999 | EP0770080B1 Novel deazapurine derivatives; a new class of crf1 specific ligands |
| 07/14/1999 | EP0759079B1 DNA ENCODING PRECURSOR OF INTERLEUKIN-1-BETA CONVERTING ENZYME-RELATED CYSTEINE PROTEINASE III (ICE rel-III) |
| 07/14/1999 | EP0754234B1 DNA ENCODING PRECURSOR OF INTERLEUKIN-1 BETA CONVERTING ENZYME-RELATED CYSTEINE PROTEINASE II (ICE rel-II) |
| 07/14/1999 | EP0665833B1 Dopamine receptor subtype ligands |
| 07/14/1999 | EP0619729B1 Composition to help stop smoking |
| 07/14/1999 | EP0581856B1 Method of preventing nmda receptor complex-mediated neuronal damage |
| 07/14/1999 | CN1222521A 1,3,8-triaza-spiro [4,5] decan-4-on derivatives |
| 07/14/1999 | CN1222516A Naphth oxazines derivvs., process for their preparation and pharmaceutical compositions containing them |
| 07/14/1999 | CN1222376A Decoction for treatment of mental diseases |
| 07/13/1999 | US5922887 Novel delta opiod modulators for the treatment or prophylaxis of pain, organ transplant rejection, diarrhea, epileptic seizures, neurological diseases, and other disorders |
| 07/13/1999 | US5922879 N-aminoalkyl-2-anthraquinonecarboxamides: new dopamine receptor subtype specific ligands |
| 07/13/1999 | US5922876 Preparation of oxymorphone from morphine |
| 07/13/1999 | US5922875 Aromatic acid diamides with antigastrin activity, a method for their preparation and their pharmaceutical use |
| 07/13/1999 | US5922868 1-(4,4-ethylenedioxy-3-methylpentyl)-3-methyl-7-propylxanthine |
| 07/13/1999 | US5922772 Therapeutic substituted guanidines |
| 07/13/1999 | US5922761 Methods for in vivo reduction of iron levels and compositions useful therefor |
| 07/13/1999 | US5922748 Indole derivatives as 5-HT agonists |
| 07/13/1999 | US5922740 Antiinflammatory agents |
| 07/13/1999 | US5922739 Antiischemic agents |
| 07/13/1999 | US5922736 Chronic, bolus administration of D-threo methylphenidate |
| 07/13/1999 | US5922735 4-aryl-3-hydroxyquinolin-2-one derivatives as ion channel modulators |
| 07/13/1999 | US5922733 Administering to treat central nervous system disorders such as anxiety, depression, epilepsy, obsessive compulsive disorders, anorexia, bulimia and alzheimer's disease |
| 07/13/1999 | US5922731 Anxiolytic agents, antiepileptic agents, anticonvulsants; treatment for sleeplessness, muscle spasms, benzodiazepinedrug overdose |
| 07/13/1999 | US5922725 Benzimidazole compounds and their use as modulators of the GABAA receptor complex |
| 07/13/1999 | US5922724 Benzimidazole compounds and their use as modulators of the GABA a receptor complex |
| 07/13/1999 | US5922716 Alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (ampa) receptor antagonists, non-competitive n-methyl-d-aspartate (nmda) receptor antagonists |
| 07/13/1999 | US5922705 Rapid narcotic detoxification |
| 07/13/1999 | US5922700 Kit for drug delivery of steroids |
| 07/13/1999 | US5922590 Hic-1 is a marker which can be used diagnostically, prognostically and therapeutically over the course of such disorders. |
| 07/13/1999 | US5922572 Polynucleotides encoding haemopoietic maturation factor |
| 07/13/1999 | US5922546 Human disintegrin metalloprotease KUZ gene |
| 07/13/1999 | CA1340640C Regulation of enzymes which utilize tetrahydrobiopterin or tetrahydrofolate cofactors with 6,6-disubstituted-tetrahydropteridines |
| 07/08/1999 | WO1999033849A1 Prodrugs of naaladase inhibitors |
| 07/08/1999 | WO1999033836A1 3'-epimeric k-252a derivatives |
| 07/08/1999 | WO1999033822A1 Indole derivatives useful a.o. for the treatment of osteoporosis |
| 07/08/1999 | WO1999033821A1 Benzopyran and benzothiopyran derivatives having retinoid antagonist-like activity |
| 07/08/1999 | WO1999033806A1 4-[aryl(piperidin-4-yl)] aminobenzamides which bind to the delta-opioid receptor |
| 07/08/1999 | WO1999033801A1 Tripeptidyl peptidase inhibitors |
| 07/08/1999 | WO1999033797A1 NEW CRYSTALLINE POLYMORPHIC FORM OF 1-METHYL-5-p-TOLUOYLPYRROLE-2-ACETAMIDOACETIC ACID GUAIACYL ESTER (MED 15) |
| 07/08/1999 | WO1999033476A1 Hyperhydrated citicoline, process and use |
| 07/08/1999 | WO1999033469A1 Benzoxazine compounds for enhancing synaptic response |
| 07/08/1999 | WO1999033466A1 Pharmaceutical composition for oral administration |
| 07/08/1999 | WO1999033455A1 Tetracycline and/or tetracycline derivative(s) for treating, suppressing and preventing of cerebrovascular diseases of nervous system |
| 07/08/1999 | WO1999025686B1 Cyclic amine derivatives and their use as drugs |
| 07/08/1999 | WO1999021574A3 Enhancement of morphogen activity |
| 07/08/1999 | WO1999020291A3 Pharmaceutical grade ginkgo biloba |
| 07/08/1999 | CA2317090A1 Tetracycline and/or tetracycline derivative(s) for treating, suppressing and preventing of cerebrovascular diseases of nervous system |
| 07/08/1999 | CA2316989A1 Hyperhydrated citicoline, process and use |
| 07/08/1999 | CA2316385A1 Prodrugs of naaladase inhibitors |
| 07/08/1999 | CA2316341A1 4-[aryl(piperidin-4-yl)] aminobenzamides which bind to the delta-opioid receptor |
| 07/08/1999 | CA2315723A1 Indole derivatives useful a.o. for the treatment of osteoporosis |
| 07/07/1999 | EP0927257A2 Human protein kinases |
| 07/07/1999 | EP0927248A1 Secreted proteins and polynucleotides encoding them |
| 07/07/1999 | EP0927192A1 Modified aminoacids, pharmaceuticals containing these compounds and method for their production |
| 07/07/1999 | EP0927191A2 Anti-inflammatory peptides and uses thereof |
| 07/07/1999 | EP0927190A1 Central nervous system-derived immune privilege factor and uses thereof |
| 07/07/1999 | EP0927184A1 3-substituted pyrido 4',3':4,5]thieno 2,3-d]pyrimidine derivatives, their preparation and their use |
| 07/07/1999 | EP0927183A1 Spirocyclic metalloprotease inhibitors |
| 07/07/1999 | EP0927171A1 Pyrazinones and triazinones and their derivatives thereof |
| 07/07/1999 | EP0927170A1 Piperazino derivatives as neurokinin antagonists |
| 07/07/1999 | EP0927156A1 Biphenyl butyric acids and their derivatives as inhibitors of matrix metalloproteinases |
| 07/07/1999 | EP0927026A1 Pharmaceutical compositions containing amisulpride and their therapeutic applications |
| 07/07/1999 | EP0636027B1 Angiotensin ii antagonists against disorders associated with impaired neuronal conduction velocity, especially diabetic neuropathy |
| 07/07/1999 | CN1222077A Fase-dissolving galanthamine hydrobromide tablet |
| 07/07/1999 | CN1221743A Substituted heterocyclic benzoeycloalkenes and the use thereof as substances having analgesic effect |
| 07/07/1999 | CN1221734A New naphthalene compounds, process for their preparation and pharmaceutical compositions containing them |
| 07/07/1999 | CN1043994C Thionaphthene diazepine compound, its prodn. method and application |
| 07/07/1999 | CN1043990C Imidazolidinone derivative, acid-addition salt therefor and remedy for senile dementia |
| 07/06/1999 | US5919954 Stereoselective process for producing dihydro-2,3-benzodiazepine derivatives |
| 07/06/1999 | US5919936 Nitropyridine compound |
| 07/06/1999 | US5919932 Biphenylamide derivatives as 5HT1D antagonists |
| 07/06/1999 | US5919904 Response regulator polypeptides; screening for bactericides |
| 07/06/1999 | US5919829 Gastrin and cck receptor ligands |
| 07/06/1999 | US5919814 Heterocyclic compounds |
| 07/06/1999 | US5919811 Neurodegenerative disorders |
| 07/06/1999 | US5919809 3-substituted-2-oxindole derivatives |
| 07/06/1999 | US5919805 Hetrocyclic compounds and their preparation and use |
| 07/06/1999 | US5919804 Use of levobupivacaine in facial surgery |
| 07/06/1999 | US5919803 3-benzylamino-2-phenylpiperidines as neurokinin antagonists |
| 07/06/1999 | US5919802 Methods of preventing and/or treating temporal lobe epilepsy |
| 07/06/1999 | US5919798 4-heteroaryl-1-piperidinealkanols and derivatives thereof and their therapeutic utility |
| 07/06/1999 | US5919789 Xanthines and their therapeutic use |
| 07/06/1999 | US5919788 4-(1H-indol-1-yl)-1-piperidinyl derivatives |
| 07/06/1999 | US5919784 Anxiety, depression |
| 07/06/1999 | US5919781 Use of NK-1 receptor antogonists for treating substance use disorders |
| 07/06/1999 | US5919778 Alzheimer*s disease |
| 07/06/1999 | US5919760 Method for treating acute and severe diarrhea |
| 07/06/1999 | US5919660 Human requiem |
| 07/06/1999 | US5919653 A recombinantly altered nucleotide sequence that codes for a neurotransmitter protein; treatment of epilepsy, stroke, multiple sclerosis, spinal cord injury, and other nervous system disorders |
| 07/06/1999 | US5919485 Oral 2-methyl-thieno-benzodiazepine formulation |
| 07/06/1999 | US5919455 Non-antigenic branched polymer conjugates |
| 07/06/1999 | CA2177146C Heterocyclic benzenesulfonylimine derivatives as inhibitors of il-1 action |
| 07/06/1999 | CA2157397C Indole derivatives as 5-ht1-like agonists for use in migraine |
| 07/06/1999 | CA2131991C Treatment of migraine |
| 07/06/1999 | CA2009578C Excitatory amino acid receptor antagonists |
| 07/01/1999 | WO1999032643A2 Mood disorder gene |